Literature DB >> 1895664

SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis.

J Connor1, R Buttyan, C A Olsson, V D'Agati, K O'Toole, I S Sawczuk.   

Abstract

The onset of hydronephrosis following unilateral ureteral obstruction is associated with the induced expression of RNA and proteins encoded by the SGP-2 gene. SGP-2 expression has been shown to demarcate mammalian cells undergoing apoptosis. Using in situ hybridization, the cellular localization of SGP-2 expression in the obstructed kidney was determined as a means to study the various phases involved in the progression of hydronephrosis. Within 30 minutes of obstruction, SGP-2 mRNA expression was localized to the adventitial layers of the hilar arteries and intrarenal arterioles. Increasing time of obstruction resulted in the notable absence or depletion of this layer. In addition, the pattern of SGP-2 expression changed with time to the collecting ducts and distal tubules. This study identifies the vascular support tissue of the kidney as the initial site of reaction and potential cell death following ureteral obstruction. We believe that this observation may be of importance in explaining the early alterations in blood flow associated with hydronephrosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895664     DOI: 10.1038/ki.1991.139

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin E Gleave; Toby Zellweger; Kim Chi; Hideaki Miyake; Satoshi Kiyama; Laura July; Simon Leung
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

Review 2.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 3.  Androgens and prostate cancer.

Authors:  Alan I So; Antonio Hurtado-Coll; Martin E Gleave
Journal:  World J Urol       Date:  2003-10-29       Impact factor: 4.226

4.  Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells.

Authors:  B M Kim; S Y Kim; S Lee; Y J Shin; B H Min; M Bendayan; I S Park
Journal:  Diabetologia       Date:  2006-01-13       Impact factor: 10.122

Review 5.  Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.

Authors:  Martin Gleave; Hideaki Miyake
Journal:  World J Urol       Date:  2005-01-26       Impact factor: 4.226

Review 6.  Mechanisms of the development of androgen independence in prostate cancer.

Authors:  Alan So; Martin Gleave; Antonio Hurtado-Col; Colleen Nelson
Journal:  World J Urol       Date:  2005-01-27       Impact factor: 4.226

7.  Tubular up-regulation of clusterin mRNA in murine lupus-like nephritis.

Authors:  S Moll; P A Menoud; L French; A P Sappino; Y Pastore; J A Schifferli; S Izui
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis.

Authors:  L McLaughlin; G Zhu; M Mistry; C Ley-Ebert; W D Stuart; C J Florio; P A Groen; S A Witt; T R Kimball; D P Witte; J A Harmony; B J Aronow
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Clusterin gene expression in the rat thymus is not modulated by dexamethasone treatment.

Authors:  L E French; A P Sappino; J Tschopp; J A Schifferli
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

10.  Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus.

Authors:  L E French; A P Sappino; J Tschopp; J A Schifferli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.